SICOS contribution to the public consultation on the revision of the EU general pharmaceutical legal framework SICOS is the French industrial sector group representing the manufacturers of Active Pharmaceutical Ingredients (API), excipients and intermediates located in France.
SIC
SICOS
Industry association · France · EU Transparency Register 803692452723-79
2
positions filed
in the 673 files tracked
2
legislative files
of 673 tracked
1
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 673 consultation files tracked so far (58,314 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 411 trade unions and professional associations on this site, they rank #263 by legislative files engaged, a count of participation, not a measure of influence.
0.5
declared lobbying FTE
self-declared
€10K+
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2024
in the register since
Declares membership of
- France Chimie : https://www.francechimie.fr/
- EFCG : https://efcg.cefic.org/
- Fefis : https://www.fefis.fr/
Self-declared to the EU Transparency Register (snapshot 20 Oct 2026).
- Register category
- Trade unions and professional associations
- Registered as
- syndicat de l’industrie chimique organique de synthèse et de la biochimie (Sicos)
- Head office
- PUTEAUX, France
Self-declared to the EU Transparency Register (snapshot 20 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track SICOS in PolicySpeak: request access →
Work at SICOS? so we know who speaks for it.
Their record over time
SICOS filed 2 positions between 27 Apr 2021 and 19 May 2025, across 2 of the 673 legislative files tracked here, attaching a full position paper 1 time.
2021 · 1 filed2025 · 1 filed
What they argued
SICOS welcomes the need to strengthen the value chains of critical medicines by supporting and valuing a sustainable and efficient industrial base in Europe on the European agenda. This topic has been raised for many years by SICOS, which warns about the impact of the deterioration of our industrial fabric and the race for the lowest price on the availability of critical medicines…
Filed in French · English published by the European Commission
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put SICOS next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.
Showing 5 of 66.
Is this your organization?
Everything on this page comes from SICOS’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.